Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
99,86 EUR | 0,00% | +0,46% | +7,10% |
05/06 | Mib hoger bij start, DiaSorin hoger op FDA-nieuws | AN |
05/06 | US FDA geeft Diasorin's Liaison Plex Yeast Blood Culture Assay goedkeuring | AN |
Omzet 2024 * | 1,19 mld. 1,28 mld. | Omzet 2025 * | 1,28 mld. 1,37 mld. | Marktkapitalisatie | 5,32 mld. 5,73 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 192 mln. 207 mln. | Nettowinst (verlies) 2025 * | 216 mln. 233 mln. | EV/omzet 2024 * | 5,07 x |
Nettoschuld 2024 * | 697 mln. 751 mln. | Nettoschuld 2025 * | 511 mln. 551 mln. | EV/omzet 2025 * | 4,57 x |
K/w-verhouding 2024 * |
30,1
x | K/w-verhouding 2025 * |
26
x | Werknemers | 3.209 |
Dividendrendement 2024 * |
0,91% | Dividendrendement 2025 * |
1,06% | Vrij verhandelbaar | 37,83% |
Recentste transcriptie over DiaSorin S.p.A.
1 week | +0,46% | ||
Lopende maand | +0,93% | ||
1 maand | +1,34% | ||
3 maanden | +2,95% | ||
6 maanden | +10,66% | ||
Lopend jaar | +7,10% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Carlo Rosa
CEO | Chief Executive Officer | 58 | 01-01-98 |
Director of Finance/CFO | 53 | 01-01-11 | |
Director/Board Member | 61 | 01-01-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 66 | 29-04-22 | |
Michele Denegri
CHM | Chairman | 55 | 26-03-07 |
Carlo Rosa
CEO | Chief Executive Officer | 58 | 01-01-98 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.76% | 15 M€ | -4,01% | ||
0.69% | 5 M€ | +12,55% | ||
0.17% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-06-24 | 99,86 | -1,66% | 74 971 |
07-06-24 | 101,6 | +0,84% | 90 503 |
06-06-24 | 100,7 | +0,20% | 66 829 |
05-06-24 | 100,5 | +1,01% | 74 454 |
04-06-24 | 99,5 | +0,10% | 95 242 |
Real Time Borsa Italiana, 10 juni 2024 om 17:44 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,10% | 5,85 mld. | |
-8,60% | 11,98 mld. | |
-5,68% | 8 mld. | |
+27,87% | 5,54 mld. | |
-15,84% | 3,84 mld. | |
+10,70% | 2,66 mld. | |
-60,36% | 2,62 mld. | |
-8,22% | 2,33 mld. | |
+15,94% | 2 mld. | |
-8,85% | 1,78 mld. |